28/09/2025
Today, Dr Koh delivered a keynote presentation at the 34th Singapore Pharmacy Congress, marking the 120th anniversary of the Pharmaceutical Society of Singapore. Titled 'More Than Itch, Advancing Atopic Dermatitis Care Through IL-31 Inhibition', Dr Koh's lecture centered on cutting-edge treatments for Atopic Dermatitis, specifically highlighting Nemolizumab, a pioneering IL-31 inhibitor that promises to rapidly and safely alleviate recalcitrant itch in patients with moderate to severe eczema. Hopefully, these advanced therapies will benefit more patients. ððð